JP2023522676A5 - - Google Patents
Info
- Publication number
- JP2023522676A5 JP2023522676A5 JP2022563172A JP2022563172A JP2023522676A5 JP 2023522676 A5 JP2023522676 A5 JP 2023522676A5 JP 2022563172 A JP2022563172 A JP 2022563172A JP 2022563172 A JP2022563172 A JP 2022563172A JP 2023522676 A5 JP2023522676 A5 JP 2023522676A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063014090P | 2020-04-22 | 2020-04-22 | |
| US63/014,090 | 2020-04-22 | ||
| US202063014573P | 2020-04-23 | 2020-04-23 | |
| US63/014,573 | 2020-04-23 | ||
| PCT/US2021/028679 WO2021216899A1 (en) | 2020-04-22 | 2021-04-22 | Il4/il13 receptor molecules for veterinary use |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023522676A JP2023522676A (ja) | 2023-05-31 |
| JP2023522676A5 true JP2023522676A5 (https=) | 2024-05-02 |
| JPWO2021216899A5 JPWO2021216899A5 (https=) | 2024-05-02 |
| JP7821741B2 JP7821741B2 (ja) | 2026-02-27 |
Family
ID=78270112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563172A Active JP7821741B2 (ja) | 2020-04-22 | 2021-04-22 | 動物用のｉｌ４／ｉｌ１３受容体分子 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240270819A1 (https=) |
| EP (1) | EP4139344A4 (https=) |
| JP (1) | JP7821741B2 (https=) |
| KR (1) | KR20230005880A (https=) |
| CN (1) | CN116034112A (https=) |
| AU (1) | AU2021259785A1 (https=) |
| BR (1) | BR112022021204A2 (https=) |
| CA (1) | CA3173927A1 (https=) |
| MX (1) | MX2022013149A (https=) |
| WO (1) | WO2021216899A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102460040B1 (ko) | 2016-04-27 | 2022-11-01 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| WO2018156180A1 (en) | 2017-02-24 | 2018-08-30 | Kindred Biosciences, Inc. | Anti-il31 antibodies for veterinary use |
| US11970526B2 (en) | 2017-04-21 | 2024-04-30 | Elanco Us Inc. | IL4/IL13 receptor molecule for veterinary use |
| BR112020002871A2 (pt) | 2017-08-15 | 2020-07-28 | Kindred Biosciences, Inc. | variantes fc de igg para uso veterinário |
| US12428466B2 (en) | 2018-10-25 | 2025-09-30 | Elanco Us Inc. | IL4/IL13 receptor molecule for veterinary use |
| WO2025141037A1 (en) * | 2023-12-28 | 2025-07-03 | Elanco Animal Health Gmbh | Il-4/il-13 and il-4/il-13/il-31 receptor trap constructs |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998023289A1 (en) * | 1996-11-27 | 1998-06-04 | The General Hospital Corporation | MODULATION OF IgG BINDING TO FcRn |
| SG10201404273QA (en) | 2003-12-23 | 2014-10-30 | Genentech Inc | Novel anti-il 13 antibodies and uses thereof |
| AU2005219837A1 (en) | 2004-02-27 | 2005-09-15 | Regeneron Pharmaceuticals, Inc. | IL-4/IL-13 sepecific polypetides and therapeutic uses thereof |
| EP2596802A1 (en) * | 2011-11-23 | 2013-05-29 | PLS-Design GmbH | Pharmaceutical composition for treatment of allergic reactions |
| US20170290889A1 (en) * | 2016-04-11 | 2017-10-12 | New York University | Methods and compositions for treating dysbiosis and gastrointestinal and inflammatory disorders |
| CN110267674A (zh) * | 2016-07-08 | 2019-09-20 | 奥美药业有限公司 | 包含瘦素的融合蛋白及其生产和使用方法 |
| WO2018073185A1 (en) | 2016-10-17 | 2018-04-26 | Vetoquinol Sa | Modified antibody constant region |
| US11970526B2 (en) * | 2017-04-21 | 2024-04-30 | Elanco Us Inc. | IL4/IL13 receptor molecule for veterinary use |
| WO2024145280A2 (en) * | 2022-12-27 | 2024-07-04 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
| EP4642795A2 (en) * | 2022-12-27 | 2025-11-05 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
-
2021
- 2021-04-22 BR BR112022021204A patent/BR112022021204A2/pt unknown
- 2021-04-22 CN CN202180036305.6A patent/CN116034112A/zh active Pending
- 2021-04-22 CA CA3173927A patent/CA3173927A1/en active Pending
- 2021-04-22 US US17/996,549 patent/US20240270819A1/en active Pending
- 2021-04-22 JP JP2022563172A patent/JP7821741B2/ja active Active
- 2021-04-22 MX MX2022013149A patent/MX2022013149A/es unknown
- 2021-04-22 WO PCT/US2021/028679 patent/WO2021216899A1/en not_active Ceased
- 2021-04-22 KR KR1020227040170A patent/KR20230005880A/ko active Pending
- 2021-04-22 AU AU2021259785A patent/AU2021259785A1/en active Pending
- 2021-04-22 EP EP21793671.5A patent/EP4139344A4/en active Pending